METHOD OF DETERMINING EYE FUNDUS CONDITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CASE OF DIABETIC RETINOPATHY, COMBINED WITH AGE-RELATED MACULAR DEGENERATION Russian patent published in 2015 - IPC A61B3/00 

Abstract RU 2564142 C1

FIELD: medicine.

SUBSTANCE: morphological changes of patient's retina and degree of changes of thresholds of macular zone (MZ) light sensitivity, level of glycosylated haemoglobin (G) in patient's blood plasma, levels of vascular endothelium growth factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) in lacrimal fluid are determined. On this basis obtained are criteria R1-R5, differentially determining patient's eye fundus condition, where R1 characterises expression of oedema on retina volume, R2 -degree of change of thresholds of MZ light sensitivity, taking into account light stimulus intensity, R3 - interaction between retina changes and degree of DM compensation, characterised by blood G level, R4 - interaction between retina changes and VEGF level in lacrimal fluid, R5 - interaction between retina changes and MCP-1 level in lacrimal fluid. Virtual areas of parameters of normal eye fundus condition for groups of criteria: R1, R3, R4, R5 and R2, R3, R4, R5 are formed by preliminarily determined values of criteria R1-R5, corresponding to normal eye fundus condition. Values of the same criteria, obtained from the patient, are used to build regression lines for the same groups of criteria: R1, R3, R4, R5 and R2, R3, R4, R5, characterising current condition of patient's eye fundus. After that, respective formed areas of existing of normal eye fundus condition parameters and regression lines of current condition of patient's eye fundus are superposed. By the data of position of points of crossing of respective formed areas and regression lines criteria R1tot and R2tot are determined. After that criterion Restimation is calculated by formula; Restimation = √A, where A = R21tot + R22tot. If Restimation is < 0.5, condition of eye fundus is estimated as unsatisfactory and requiring medicinal procedures. If Restimation is > 0.5, eye fundus condition is considered to be satisfactory.

EFFECT: objective complex diagnostic approach, taking into account interaction of morphological, clinical-and-functional and biochemical indices, accurate estimation of eye fundus condition in case of said combined pathology of patient, detection of risk of disease progressing.

6 cl, 8 dwg, 2 ex

Similar patents RU2564142C1

Title Year Author Number
METHOD FOR PREDICTION OF PROGRESSION OF DIABETIC RETINOPATHY AND DIABETIC MACULAR OEDEMA 2013
  • Moshetova Larisa Konstantinovna
  • Vorob'Eva Irina Vital'Evna
  • Merkushenkova Dar'Ja Aleksandrovna
  • Podguzov Gennadij Vasil'Evich
  • Alekhnovich Valentin Ivanovich
RU2520826C1
METHOD FOR EARLY DIAGNOSTICS AND PREDICTION OF DIABETIC AND HYPERTENSIVE RETINOPATHY PROGRESSING IN CASE OF COMBINED COURSE OF TYPE 2 DIABETES MELLITUS AND HYPERTENSIVE DISEASE 2015
  • Moshetova Larisa Konstantinovna
  • Vorobeva Irina Vitalevna
  • Gigineishvili Daredzhan Nugzarevna
  • Alekhnovich Valentin Ivanovich
  • Yarovaya Galina Alekseevna
  • Neshkova Elena Andreevna
RU2610535C1
METHOD FOR PREDICTING THE DEVELOPMENT OF DIABETIC RETINOPATHY IN THE POSTOPERATIVE PERIOD OF COMBINED KIDNEY AND PANCREAS TRANSPLANTATION 2021
  • Vorobeva Irina Vitalevna
  • Moshetova Larisa Konstantinovna
  • Sychev Dmitrij Alekseevich
  • Pinchuk Aleksej Valerevich
  • Bulava Evgenij Valerevich
  • Lazareva Kseniya Evgenevna
  • Zhuravel Nikita Sergeevich
RU2785270C1
METHOD OF PREDICTION OF PROGRESSION OF OPEN-ANGLE GLAUCOMA IN COMBINATION WITH DIABETIC RETINOPATHY IN PATIENTS WITH DIABETES 2015
  • Vorobeva Irina Vitalevna
  • Alekhnovich Valentin Ivanovich
  • Shcherbakova Ekaterina Vladimirovna
RU2603300C1
METHOD FOR PREDICTING THE DEVELOPMENT OF DIABETIC RETINOPATHY IN PATIENTS WITH GERIATRIC SYNDROMES 2022
  • Lev Inna Valerevna
  • Agarkov Nikolaj Mikhajlovich
  • Fabrikantov Oleg Lvovich
RU2779940C1
TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS 2018
  • Hopkins, Jill
  • Tsuruda, Pam
  • Chapman, Claude
  • Sweigard, Harry
  • Poon, Yan
  • Marquess, Daniel
  • David, Nathaniel
  • Dananberg, Jamie
  • Laberge, Remi-Martin
RU2815482C2
NEUTRAL ENDOPEPTIDASE (NEP) AND SOLUBLE HUMAN ENDOPEPTIDASE (SHE) INHIBITORS FOR PREVENTION AND TREATMENT OF EYE DISEASES 2019
  • Turski Kristofer
RU2758771C1
METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF MELANOMA OF THE CHOROID OF THE CENTRAL LOCALIZATION AND THE LATE STAGE OF AGE-RELATED MACULAR DEGENERATION 2022
  • Balatskaya Natalya Vladimirovna
  • Saakyan Svetlana Vagovna
  • Myakoshina Elena Borisovna
  • Vorobeva Elena Pavlovna
  • Kulikova Irina Gennadevna
RU2792554C1
DERIVATIVES OF N-UREA-SUBSTITUTED AMINOACIDS AS MODULATORS OF FORMYL-PEPTIDE RECEPTOR 2014
  • Bird Richard L.
  • Duong Ten T.
  • Donello Dzhon E.
  • Visvanat Vina
  • Garst Majkl E.
RU2696581C2
METHOD FOR PREDICTING CLINICAL MANIFESTATIONS OF DIABETIC RETINOPATHY IN II TYPE DIABETES PATIENTS 2005
  • Sorokin Evgenij Leonidovich
  • Pshenichnov Maksim Valer'Evich
RU2292549C1

RU 2 564 142 C1

Authors

Vorob'Eva Irina Vital'Evna

Mikhaleva Ljubava Gennadievna

Alekhnovich Valentin Ivanovich

Podguzov Gennadij Vasil'Evich

Dates

2015-09-27Published

2014-05-22Filed